Rentschler Biopharma has appointed Mark Caswell as VP, site head for its U.S. facility.
Caswell will manage the company’s operations at its facilities in Milford, Massachusetts. He has more than two decades of industry experience, most recently as head of operations at the Portsmouth, New Hampshire facility of Lonza Biologicals. Caswell also worked at Sanofi Genzyme, serving as director of global engineering and technology.
“Mark’s many years of experience in the biopharma and CDMO space and diverse background in various areas of operations make him the perfect leader to run our U.S. operations,” said Rentschler CEO Dr. Frank Mathias in a statement.
